Allogene Therapeutics (ALLO) Goodwill & Intangibles (2018 - 2019)
Allogene Therapeutics' (ALLO) quarterly Goodwill & Intangibles came in at $151000.0 in Q4 2019, down 79.97% year-on-year from $754000.0 in Q4 2018, and down 49.83% quarter-over-quarter from $301000.0 in Q3 2019.
Allogene Therapeutics (ALLO) Goodwill & Intangibles (2018 - 2019) Analysis & Trends
Allogene Therapeutics has disclosed Goodwill & Intangibles across 2 years of filings, most recently posting $151000.0 for Q4 2019.
- Goodwill & Intangibles for Q4 2019 came in at $151000.0, down 79.97% year-over-year; the trailing twelve-month figure through Dec 2019 was $151000.0 (down 79.97% YoY), and the FY2019 annual result was $151000.0, down 79.97% from the prior year.
- Goodwill & Intangibles came in at $151000.0 for Q4 2019 at Allogene Therapeutics, down from $301000.0 in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $904000.0 in Q3 2018 to a low of $151000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Allogene Therapeutics | 482.98 Mn | 482.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 151,000.00 |
| Sep 30, 2019 | 301,000.00 |
| Jun 30, 2019 | 452,000.00 |
| Mar 31, 2019 | 603,000.00 |
| Dec 31, 2018 | 754,000.00 |
| Sep 30, 2018 | 904,000.00 |